Evidence map›Paper›PMID 37679635›Full record

ArticleMethods in molecular biology (Clifton, N.J.)2023

Validation and the Determination of Antibody Bioactivity Using MILKSHAKE and Sundae Protocols.

Mary R Ferguson, Qiana M Mendez, Felicity E Acca, Cassandra D Chapados, Holland A Driscoll, Kezzia S Jones, Gregory Mirando, Michael P Weiner, Xiaofeng Li

Abstract read
In one paragraph

Article in Methods in molecular biology (Clifton, N.J.), 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Epivolve: A Protocol for Site-Directed Antibodies.Methods in molecular biology (Clifton, N.J.) · 2023
    Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Mary R FergusonAbbratech, Inc., Branford, CT, USA. mferguson@abbratech.com.
Qiana M MendezAbbratech, Inc., Branford, CT, USA.
Felicity E AccaAbbratech, Inc., Branford, CT, USA.
Cassandra D ChapadosAbbratech, Inc., Branford, CT, USA.
Holland A DriscollAbbratech, Inc., Branford, CT, USA.
Kezzia S JonesAbbratech, Inc., Branford, CT, USA.
Gregory MirandoAbbratech, Inc., Branford, CT, USA.
Michael P WeinerAbbratech, Inc., Branford, CT, USA.
Xiaofeng LiAbbratech, Inc., Branford, CT, USA.

Funding

Method for the validation by Western analysis of affinity reagents against post-translationally modified proteins.R44GM146473 · NIGMS · ABBRATECH, INC. · PI WEINER, MICHAEL P · 2023 to 2024
$2.2M
Platform for the High Throughput Generation and Validation of Affinity ReagentsR44GM148998 · NIGMS · ABBRATECH, INC. · PI WEINER, MICHAEL P · 2023 to 2024
$2.2M
DIRECTED DISCOVERY AND VALIDATION OF ANTI-SPLICE-JUNCTION SITE AbsR44GM156476 · NIGMS · ABBRATECH, INC. · PI MICHAEL P WEINER · 2024 to 2026
$1.1M
Method for the validation by Western analysis of affinity reagents against post-translationally modified proteins. I. survey of existing antibodies, and II. development of method improvementsR43GM146473 · NIGMS · ABBRATECH, INC. · PI WEINER, MICHAEL P · 2022 to 2022
$339k
NIGMS NIH HHS R43 GM146473NIGMS NIH HHS R44 GM146473NIGMS NIH HHS R44 GM148998NIGMS NIH HHS R44 GM156476
6 · The paper itself

Abstract

To develop reproducible results, it is critical that all reagents used in an experiment be validated in an alternative or independent method. We present two such independent methods for determining the specificity of antibodies: (1) "MILKSHAKE," which can be used to validate the liability and specificity of antibodies directed against post-translationally-modified epitopes, and (2) "Sundae," which is a more complete alanine-like scanning method that can be used to better understand the binding and bioactivity of specific residues of a protein. We apply both of these methods to the interaction between an antibody and its antigen.

Indexed as

AlanineAntibodiesEpitopesAlanineAntibodiesEpitopesAlanine scanningAntibody specificityAntibody validationELISAWestern

Identifiers

PMID37679635
PMCPMC10568615

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.